We support a strong regulatory framework for pharmaceutical pricing which ensures value and an environment which delivers the best possible care for patients.
BMC Positions:
Submission to Finance Canada: Priorities for the Federal Budget (February 18, 2021)

Submission to the Standing Committee on Health: PMPRB Guidelines (November 6, 2020) (français)

Media advisory: PMPRB reforms risk access to drugs, patient organizations warn (October 23, 2020)

Letter to the Minister of Health (August 10, 2020) (français)

Submission to the House of Commons Standing Committee on Finance (August 2020)

Submission Regarding PMPRB Revised Draft Guidelines (August 2020) (français)

Letter to the Minister of Health (June 19, 2020) (français)

Submission to the House of Commons Standing Committee on Health (May 2020)

Draft Guidelines to Implement the Patented Medicines Regulations, as amended (February 2020)

Proposed Patented Medicines Regulations (February 2018)

PMPRB Modernization (October 2016)